This is the authors' abstract. We don't add key points for this paper.
The Aurora kinases are a group of serine/threonine protein kinases that regulate key steps during mitosis, and deregulation of these proteins (e.g., by gene amplification or overexpression) has been linked to a wide variety of tumor types. Thus, Aurora-A and Aurora-B have been intensely studied as targets for anticancer therapy and are now clinically validated targets. Here we report on the development of a novel fluorescence intensity binding assay for Aurora-A kinase inhibitors using a fluorescently labeled probe compound that shows intramolecular quenching when unbound but exhibits a dramatic increase in fluorescence when bound to Aurora-A.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Slatter et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: